KITLG and neoplasm: Choi et al. applied a proprietary NUFSTM process, utilizing SCF extraction of fatty excipients, to generate carrier-minimized docetaxel nanoparticles with superior tumor accumulation and reduced toxicity versus commercial TaxotereTM, underscoring the potential of SCF methods for clinical translation (Figure 9C) [109].